Cargando…

Common variants in glyoxalase I do not increase chronic pancreatitis risk

INTRODUCTION: Chronic pancreatitis (CP) may be caused by oxidative stress. An important source of reactive oxygen species (ROS) is the methylglyoxal-derived formation of advanced glycation endproducts (AGE). Methylglyoxal is detoxified by Glyoxalase I (GLO1). A reduction in GLO1 activity results in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaune, Tom, Hollenbach, Marcus, Keil, Bettina, Chen, Jian-Min, Masson, Emmanuelle, Becker, Carla, Damm, Marko, Ruffert, Claudia, Grützmann, Robert, Hoffmeister, Albrecht, te Morsche, Rene H. M., Cavestro, Giulia Martina, Zuppardo, Raffaella Alessia, Saftoiu, Adrian, Malecka-Panas, Ewa, Głuszek, Stanislaw, Bugert, Peter, Lerch, Markus M., Weiss, Frank Ulrich, Zou, Wen-Bin, Liao, Zhuan, Hegyi, Peter, Drenth, Joost PH, Riedel, Jan, Férec, Claude, Scholz, Markus, Kirsten, Holger, Tóth, Andrea, Ewers, Maren, Witt, Heiko, Griesmann, Heidi, Michl, Patrick, Rosendahl, Jonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818803/
https://www.ncbi.nlm.nih.gov/pubmed/31661534
http://dx.doi.org/10.1371/journal.pone.0222927
_version_ 1783463653196955648
author Kaune, Tom
Hollenbach, Marcus
Keil, Bettina
Chen, Jian-Min
Masson, Emmanuelle
Becker, Carla
Damm, Marko
Ruffert, Claudia
Grützmann, Robert
Hoffmeister, Albrecht
te Morsche, Rene H. M.
Cavestro, Giulia Martina
Zuppardo, Raffaella Alessia
Saftoiu, Adrian
Malecka-Panas, Ewa
Głuszek, Stanislaw
Bugert, Peter
Lerch, Markus M.
Weiss, Frank Ulrich
Zou, Wen-Bin
Liao, Zhuan
Hegyi, Peter
Drenth, Joost PH
Riedel, Jan
Férec, Claude
Scholz, Markus
Kirsten, Holger
Tóth, Andrea
Ewers, Maren
Witt, Heiko
Griesmann, Heidi
Michl, Patrick
Rosendahl, Jonas
author_facet Kaune, Tom
Hollenbach, Marcus
Keil, Bettina
Chen, Jian-Min
Masson, Emmanuelle
Becker, Carla
Damm, Marko
Ruffert, Claudia
Grützmann, Robert
Hoffmeister, Albrecht
te Morsche, Rene H. M.
Cavestro, Giulia Martina
Zuppardo, Raffaella Alessia
Saftoiu, Adrian
Malecka-Panas, Ewa
Głuszek, Stanislaw
Bugert, Peter
Lerch, Markus M.
Weiss, Frank Ulrich
Zou, Wen-Bin
Liao, Zhuan
Hegyi, Peter
Drenth, Joost PH
Riedel, Jan
Férec, Claude
Scholz, Markus
Kirsten, Holger
Tóth, Andrea
Ewers, Maren
Witt, Heiko
Griesmann, Heidi
Michl, Patrick
Rosendahl, Jonas
author_sort Kaune, Tom
collection PubMed
description INTRODUCTION: Chronic pancreatitis (CP) may be caused by oxidative stress. An important source of reactive oxygen species (ROS) is the methylglyoxal-derived formation of advanced glycation endproducts (AGE). Methylglyoxal is detoxified by Glyoxalase I (GLO1). A reduction in GLO1 activity results in increased ROS. Single nucleotide polymorphisms (SNPs) of GLO1 have been linked to various inflammatory diseases. Here, we analyzed whether common GLO1 variants are associated with alcoholic (ACP) and non-alcoholic CP (NACP). METHODS: Using melting curve analysis, we genotyped a screening cohort of 223 ACP, 218 NACP patients, and 328 controls for 11 tagging SNPs defined by the SNPinfo LD TAG SNP Selection tool and the functionally relevant variant rs4746. For selected variants the cohorts were extended to up to 1,441 patient samples. RESULTS: In the ACP cohort, comparison of genotypes for rs1937780 between patients and controls displayed an ambiguous result in the screening cohort (p = 0.08). However, in the extended cohort of 1,441 patients no statistically significant association was found for the comparison of genotypes (p = 0.11), nor in logistic regression analysis (p = 0.214, OR 1.072, 95% CI 0.961–1.196). In the NACP screening cohort SNPs rs937662, rs1699012, and rs4746 displayed an ambiguous result when patients were compared to controls in the recessive or dominant model (p = 0.08, 0.08, and 0.07, respectively). Again, these associations were not confirmed in the extended cohorts (rs937662, dominant model: p = 0.07, logistic regression: p = 0.07, OR 1.207, 95% CI 0.985–1.480) or in the replication cohorts for rs4746 (Germany, p = 0.42, OR 1.080, 95% CI 0.673–1.124; France, p = 0.19, OR 0.90, 95% CI 0.76–1.06; China, p = 0.24, OR 1.18, 95% CI 0.90–1.54) and rs1699012 (Germany, Munich; p = 0.279, OR 0.903, 95% CI 0.750–1.087). CONCLUSIONS: Common GLO1 variants do not increase chronic pancreatitis risk.
format Online
Article
Text
id pubmed-6818803
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-68188032019-11-01 Common variants in glyoxalase I do not increase chronic pancreatitis risk Kaune, Tom Hollenbach, Marcus Keil, Bettina Chen, Jian-Min Masson, Emmanuelle Becker, Carla Damm, Marko Ruffert, Claudia Grützmann, Robert Hoffmeister, Albrecht te Morsche, Rene H. M. Cavestro, Giulia Martina Zuppardo, Raffaella Alessia Saftoiu, Adrian Malecka-Panas, Ewa Głuszek, Stanislaw Bugert, Peter Lerch, Markus M. Weiss, Frank Ulrich Zou, Wen-Bin Liao, Zhuan Hegyi, Peter Drenth, Joost PH Riedel, Jan Férec, Claude Scholz, Markus Kirsten, Holger Tóth, Andrea Ewers, Maren Witt, Heiko Griesmann, Heidi Michl, Patrick Rosendahl, Jonas PLoS One Research Article INTRODUCTION: Chronic pancreatitis (CP) may be caused by oxidative stress. An important source of reactive oxygen species (ROS) is the methylglyoxal-derived formation of advanced glycation endproducts (AGE). Methylglyoxal is detoxified by Glyoxalase I (GLO1). A reduction in GLO1 activity results in increased ROS. Single nucleotide polymorphisms (SNPs) of GLO1 have been linked to various inflammatory diseases. Here, we analyzed whether common GLO1 variants are associated with alcoholic (ACP) and non-alcoholic CP (NACP). METHODS: Using melting curve analysis, we genotyped a screening cohort of 223 ACP, 218 NACP patients, and 328 controls for 11 tagging SNPs defined by the SNPinfo LD TAG SNP Selection tool and the functionally relevant variant rs4746. For selected variants the cohorts were extended to up to 1,441 patient samples. RESULTS: In the ACP cohort, comparison of genotypes for rs1937780 between patients and controls displayed an ambiguous result in the screening cohort (p = 0.08). However, in the extended cohort of 1,441 patients no statistically significant association was found for the comparison of genotypes (p = 0.11), nor in logistic regression analysis (p = 0.214, OR 1.072, 95% CI 0.961–1.196). In the NACP screening cohort SNPs rs937662, rs1699012, and rs4746 displayed an ambiguous result when patients were compared to controls in the recessive or dominant model (p = 0.08, 0.08, and 0.07, respectively). Again, these associations were not confirmed in the extended cohorts (rs937662, dominant model: p = 0.07, logistic regression: p = 0.07, OR 1.207, 95% CI 0.985–1.480) or in the replication cohorts for rs4746 (Germany, p = 0.42, OR 1.080, 95% CI 0.673–1.124; France, p = 0.19, OR 0.90, 95% CI 0.76–1.06; China, p = 0.24, OR 1.18, 95% CI 0.90–1.54) and rs1699012 (Germany, Munich; p = 0.279, OR 0.903, 95% CI 0.750–1.087). CONCLUSIONS: Common GLO1 variants do not increase chronic pancreatitis risk. Public Library of Science 2019-10-29 /pmc/articles/PMC6818803/ /pubmed/31661534 http://dx.doi.org/10.1371/journal.pone.0222927 Text en © 2019 Kaune et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Kaune, Tom
Hollenbach, Marcus
Keil, Bettina
Chen, Jian-Min
Masson, Emmanuelle
Becker, Carla
Damm, Marko
Ruffert, Claudia
Grützmann, Robert
Hoffmeister, Albrecht
te Morsche, Rene H. M.
Cavestro, Giulia Martina
Zuppardo, Raffaella Alessia
Saftoiu, Adrian
Malecka-Panas, Ewa
Głuszek, Stanislaw
Bugert, Peter
Lerch, Markus M.
Weiss, Frank Ulrich
Zou, Wen-Bin
Liao, Zhuan
Hegyi, Peter
Drenth, Joost PH
Riedel, Jan
Férec, Claude
Scholz, Markus
Kirsten, Holger
Tóth, Andrea
Ewers, Maren
Witt, Heiko
Griesmann, Heidi
Michl, Patrick
Rosendahl, Jonas
Common variants in glyoxalase I do not increase chronic pancreatitis risk
title Common variants in glyoxalase I do not increase chronic pancreatitis risk
title_full Common variants in glyoxalase I do not increase chronic pancreatitis risk
title_fullStr Common variants in glyoxalase I do not increase chronic pancreatitis risk
title_full_unstemmed Common variants in glyoxalase I do not increase chronic pancreatitis risk
title_short Common variants in glyoxalase I do not increase chronic pancreatitis risk
title_sort common variants in glyoxalase i do not increase chronic pancreatitis risk
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818803/
https://www.ncbi.nlm.nih.gov/pubmed/31661534
http://dx.doi.org/10.1371/journal.pone.0222927
work_keys_str_mv AT kaunetom commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT hollenbachmarcus commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT keilbettina commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT chenjianmin commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT massonemmanuelle commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT beckercarla commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT dammmarko commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT ruffertclaudia commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT grutzmannrobert commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT hoffmeisteralbrecht commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT temorscherenehm commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT cavestrogiuliamartina commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT zuppardoraffaellaalessia commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT saftoiuadrian commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT maleckapanasewa commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT głuszekstanislaw commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT bugertpeter commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT lerchmarkusm commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT weissfrankulrich commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT zouwenbin commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT liaozhuan commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT hegyipeter commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT drenthjoostph commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT riedeljan commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT ferecclaude commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT scholzmarkus commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT kirstenholger commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT tothandrea commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT ewersmaren commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT wittheiko commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT griesmannheidi commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT michlpatrick commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk
AT rosendahljonas commonvariantsinglyoxalaseidonotincreasechronicpancreatitisrisk